Nov 2, 2021 | 2021, Investors, Press Releases
Philogen to hold a Webinar at 11 am EST / 4 pm GMT / 5 pm CEST on Friday 12th November 2021. Register in advance for this webinar: https://us06web.zoom.us/webinar/register/WN_DF2aVOgqSRyU13cQ2hhMhg Or join by phone: Webinar ID: 826 0441 7662...Oct 28, 2021 | 2021, Investors, Press Releases
Avviso di pubblicazione della Relazione Illustrativa sulla proposta di autorizzazione all’acquisto e alla disposizione di azioni proprieOct 20, 2021 | 2021, Investors, Press Releases
20.10.2021 Comunicato stampa – Il Consiglio di Amministrazione approva la proposta di autorizzazione all’acquisto e alla disposizione di azioni proprieOct 20, 2021 | 2021, Past Events
Listen to WebcastOct 15, 2021 | 2021, Press Releases, Scientific
Philogen announces that Philochem’s European Patent 3083957 relating to important features of proprietary DNA-encoded chemical libraries (“ESAC 2+1” technology) was upheld after Oral Proceedings in front of the Opposition Division at the European Patent Office. Read...Oct 13, 2021 | 2021, Press Releases, Scientific
Philogen S.p.A. announces an update on the worldwide license agreement with Pfizer to develop Dekavil, a novel investigational therapy for the treatment of autoimmune diseases. Read more
Recent Comments